Cargando…

Variable sensitivity to complement-dependent cytotoxicity in murine models of neuromyelitis optica

BACKGROUND: Studies of neuromyelitis optica (NMO), an autoimmune disease of the central nervous system (CNS), have demonstrated that autoantibodies against the water channel aquaporin-4 (AQP4) induce astrocyte damage through complement-dependent cytotoxicity (CDC). In developing experimental models...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yiting, Harlow, Danielle E., Given, Katherine S., Owens, Gregory P., Macklin, Wendy B., Bennett, Jeffrey L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5134246/
https://www.ncbi.nlm.nih.gov/pubmed/27905992
http://dx.doi.org/10.1186/s12974-016-0767-4
_version_ 1782471429496766464
author Liu, Yiting
Harlow, Danielle E.
Given, Katherine S.
Owens, Gregory P.
Macklin, Wendy B.
Bennett, Jeffrey L.
author_facet Liu, Yiting
Harlow, Danielle E.
Given, Katherine S.
Owens, Gregory P.
Macklin, Wendy B.
Bennett, Jeffrey L.
author_sort Liu, Yiting
collection PubMed
description BACKGROUND: Studies of neuromyelitis optica (NMO), an autoimmune disease of the central nervous system (CNS), have demonstrated that autoantibodies against the water channel aquaporin-4 (AQP4) induce astrocyte damage through complement-dependent cytotoxicity (CDC). In developing experimental models of NMO using cells, tissues or animals from mice, co-administration of AQP4-IgG and normal human serum, which serves as the source of human complement (HC), is required. The sensitivity of mouse CNS cells to HC and CDC in these models is not known. METHODS: We used HC and recombinant monoclonal antibodies (rAbs) against AQP4 to investigate CDC on mouse neurons, astrocytes, differentiated oligodendrocytes (OLs), and oligodendrocyte progenitors (OPCs) in the context of purified monocultures, neuroglial mixed cultures, and organotypic cerebellar slices. RESULTS: We found that murine neurons, OLs, and OPCs were sensitive to HC in monocultures. In mixed murine neuroglial cultures, HC-mediated toxicity to neurons and OLs was reduced; however, astrocyte damage induced by an AQP-specific rAb #53 and HC increased neuronal and oligodendroglial loss. OPCs were resistant to HC toxicity in neuroglial mixed cultures. In mouse cerebellar slices, damage to neurons and OLs following rAb #53-mediated CDC was further reduced, but in contrast to neuroglial mixed cultures, astrocyte damage sensitized OPCs to complement damage. Finally, we established that some injury to neurons, OLs, and OPCs in cell and slice cultures resulted from the activation of HC by anti-tissue antibodies to mouse cells. CONCLUSIONS: Murine neurons and oligodendroglia demonstrate variable sensitivity to activated complement based on their differentiation and culture conditions. In organotypic cultures, the protection of neurons, OLs, and OPCs against CDC is eliminated by targeted astrocyte destruction. The activation of human complement proteins on mouse CNS cells necessitates caution when interpreting the results of mouse experimental models of NMO using HC. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12974-016-0767-4) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5134246
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-51342462016-12-15 Variable sensitivity to complement-dependent cytotoxicity in murine models of neuromyelitis optica Liu, Yiting Harlow, Danielle E. Given, Katherine S. Owens, Gregory P. Macklin, Wendy B. Bennett, Jeffrey L. J Neuroinflammation Research BACKGROUND: Studies of neuromyelitis optica (NMO), an autoimmune disease of the central nervous system (CNS), have demonstrated that autoantibodies against the water channel aquaporin-4 (AQP4) induce astrocyte damage through complement-dependent cytotoxicity (CDC). In developing experimental models of NMO using cells, tissues or animals from mice, co-administration of AQP4-IgG and normal human serum, which serves as the source of human complement (HC), is required. The sensitivity of mouse CNS cells to HC and CDC in these models is not known. METHODS: We used HC and recombinant monoclonal antibodies (rAbs) against AQP4 to investigate CDC on mouse neurons, astrocytes, differentiated oligodendrocytes (OLs), and oligodendrocyte progenitors (OPCs) in the context of purified monocultures, neuroglial mixed cultures, and organotypic cerebellar slices. RESULTS: We found that murine neurons, OLs, and OPCs were sensitive to HC in monocultures. In mixed murine neuroglial cultures, HC-mediated toxicity to neurons and OLs was reduced; however, astrocyte damage induced by an AQP-specific rAb #53 and HC increased neuronal and oligodendroglial loss. OPCs were resistant to HC toxicity in neuroglial mixed cultures. In mouse cerebellar slices, damage to neurons and OLs following rAb #53-mediated CDC was further reduced, but in contrast to neuroglial mixed cultures, astrocyte damage sensitized OPCs to complement damage. Finally, we established that some injury to neurons, OLs, and OPCs in cell and slice cultures resulted from the activation of HC by anti-tissue antibodies to mouse cells. CONCLUSIONS: Murine neurons and oligodendroglia demonstrate variable sensitivity to activated complement based on their differentiation and culture conditions. In organotypic cultures, the protection of neurons, OLs, and OPCs against CDC is eliminated by targeted astrocyte destruction. The activation of human complement proteins on mouse CNS cells necessitates caution when interpreting the results of mouse experimental models of NMO using HC. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12974-016-0767-4) contains supplementary material, which is available to authorized users. BioMed Central 2016-12-01 /pmc/articles/PMC5134246/ /pubmed/27905992 http://dx.doi.org/10.1186/s12974-016-0767-4 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Liu, Yiting
Harlow, Danielle E.
Given, Katherine S.
Owens, Gregory P.
Macklin, Wendy B.
Bennett, Jeffrey L.
Variable sensitivity to complement-dependent cytotoxicity in murine models of neuromyelitis optica
title Variable sensitivity to complement-dependent cytotoxicity in murine models of neuromyelitis optica
title_full Variable sensitivity to complement-dependent cytotoxicity in murine models of neuromyelitis optica
title_fullStr Variable sensitivity to complement-dependent cytotoxicity in murine models of neuromyelitis optica
title_full_unstemmed Variable sensitivity to complement-dependent cytotoxicity in murine models of neuromyelitis optica
title_short Variable sensitivity to complement-dependent cytotoxicity in murine models of neuromyelitis optica
title_sort variable sensitivity to complement-dependent cytotoxicity in murine models of neuromyelitis optica
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5134246/
https://www.ncbi.nlm.nih.gov/pubmed/27905992
http://dx.doi.org/10.1186/s12974-016-0767-4
work_keys_str_mv AT liuyiting variablesensitivitytocomplementdependentcytotoxicityinmurinemodelsofneuromyelitisoptica
AT harlowdaniellee variablesensitivitytocomplementdependentcytotoxicityinmurinemodelsofneuromyelitisoptica
AT givenkatherines variablesensitivitytocomplementdependentcytotoxicityinmurinemodelsofneuromyelitisoptica
AT owensgregoryp variablesensitivitytocomplementdependentcytotoxicityinmurinemodelsofneuromyelitisoptica
AT macklinwendyb variablesensitivitytocomplementdependentcytotoxicityinmurinemodelsofneuromyelitisoptica
AT bennettjeffreyl variablesensitivitytocomplementdependentcytotoxicityinmurinemodelsofneuromyelitisoptica